Viral dynamics model with CTL immune response incorporating antiretroviral therapy
- PMID: 22930342
- DOI: 10.1007/s00285-012-0580-3
Viral dynamics model with CTL immune response incorporating antiretroviral therapy
Abstract
We present two HIV models that include the CTL immune response, antiretroviral therapy and a full logistic growth term for uninfected CD4+ T-cells. The difference between the two models lies in the inclusion or omission of a loss term in the free virus equation. We obtain critical conditions for the existence of one, two or three steady states, and analyze the stability of these steady states. Through numerical simulation we find substantial differences in the reproduction numbers and the behaviour at the infected steady state between the two models, for certain parameter sets. We explore the effect of varying the combination drug efficacy on model behaviour, and the possibility of reconstituting the CTL immune response through antiretroviral therapy. Furthermore, we employ Latin hypercube sampling to investigate the existence of multiple infected equilibria.
Similar articles
-
The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission.Math Biosci Eng. 2019 Jul 26;16(6):6822-6841. doi: 10.3934/mbe.2019341. Math Biosci Eng. 2019. PMID: 31698590
-
Hopf bifurcation in a CTL-inclusive HIV-1 infection model with two time delays.Math Biosci Eng. 2019 Mar 22;16(4):2587-2612. doi: 10.3934/mbe.2019130. Math Biosci Eng. 2019. PMID: 31137229
-
Global stability of HIV infection of CD4+ T cells and macrophages with CTL immune response and distributed delays.Comput Math Methods Med. 2013;2013:653204. doi: 10.1155/2013/653204. Epub 2013 Dec 2. Comput Math Methods Med. 2013. PMID: 24363778 Free PMC article.
-
Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment.Philos Trans R Soc Lond B Biol Sci. 2000 Aug 29;355(1400):1059-70. doi: 10.1098/rstb.2000.0643. Philos Trans R Soc Lond B Biol Sci. 2000. PMID: 11186307 Free PMC article. Review.
-
AIDS: decline and fall of immune surveillance?Curr Biol. 1997 Mar 1;7(3):R136-40. doi: 10.1016/s0960-9822(97)70072-1. Curr Biol. 1997. PMID: 9162473 Review.
Cited by
-
A Nanobody Against Cytotoxic T-Lymphocyte Associated Antigen-4 Increases the Anti-Tumor Effects of Specific CD8+ T Cells.J Biomed Nanotechnol. 2019 Nov 1;15(11):2229-2239. doi: 10.1166/jbn.2019.2859. J Biomed Nanotechnol. 2019. PMID: 31847937 Free PMC article.
-
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy.Cell Death Dis. 2024 Jan 8;15(1):17. doi: 10.1038/s41419-023-06391-x. Cell Death Dis. 2024. PMID: 38191571 Free PMC article. Review.
-
Global Stability of Delayed Viral Infection Models with Nonlinear Antibody and CTL Immune Responses and General Incidence Rate.Comput Math Methods Med. 2016;2016:3903726. doi: 10.1155/2016/3903726. Epub 2016 Dec 15. Comput Math Methods Med. 2016. PMID: 28115980 Free PMC article.
-
Dynamics of a new HIV model with the activation status of infected cells.J Math Biol. 2021 Apr 15;82(6):51. doi: 10.1007/s00285-021-01604-3. J Math Biol. 2021. PMID: 33860365 Free PMC article.
-
A discrete-time analog for coupled within-host and between-host dynamics in environmentally driven infectious disease.Adv Differ Equ. 2018;2018(1):69. doi: 10.1186/s13662-018-1522-1. Epub 2018 Feb 26. Adv Differ Equ. 2018. PMID: 32226450 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials